RAB11B and osteosarcoma: Our results demonstrated that lnc-RAB11B-AS1 inhibits osteosarcoma cells proliferation, cell cycle progression, invasion and migration in vitro and prevents tumor growth in vivo, indicating lnc-RAB11B-AS1 as an anti-oncogene in osteosarcoma.